Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

ADIL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 14.35%

Insider Buying (Last 12 Months): $1,918.00

Insider Selling (Last 12 Months): $0.00

Adial Pharmaceuticals Insider Trading History Chart

Adial Pharmaceuticals Share Price & Price History

^$2.03

▲ +0.01 (0.50%)

As of 12/8/2023 01:00 AM ET

Days: 30 | 90 | 365

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

From Autonomix | Ad

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

Adial Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/29/2023	Kevin Schuyler	Director	Buy	700	$2.74	$1,918.00	700
11/29/2021	William B. Stilley, III	CEO	Buy	400	$64.75	$25,900.00
11/26/2021	James W. Newman, Jr.	Director	Buy	400	$71.25	$28,500.00
4/6/2021	Bankole A. Johnson	Insider	Sell	6,000	$62.50	$375,000.00	42

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

Drop everything and learn about the Income Calendar now.

SEC Filings (Institutional Ownership Changes) for Adial Pharmaceuticals (NASDAQ:ADIL)

Institutional Buying and Selling by Quarter

Adial Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/9/2023	Manchester Capital Management LLC	48,097	$0.13M	0.0%	-96.0%	3.942%
8/11/2023	BlackRock Inc.	194,364	$40K	0.0%	-13.9%	16.197%
5/16/2023	Susquehanna International Group LLP	222,283	$78K	0.0%	+144.3%	0.779%
5/12/2023	Renaissance Technologies LLC	100,900	$35K	0.0%	-59.9%	0.354%
5/9/2023	Manchester Capital Management LLC	1,202,452	$0.42M	0.1%	N/A	4.216%
2/13/2023	Renaissance Technologies LLC	251,886	$54K	0.0%	+74.6%	0.974%
11/15/2022	Citadel Advisors LLC	265,062	$93K	0.0%	+1,156.2%	1.025%
11/7/2022	Virtu Financial LLC	77,694	$27K	0.0%	+142.7%	0.301%
8/15/2022	Millennium Management LLC	39,490	$53K	0.0%	N/A	0.166%
8/13/2022	Virtu Financial LLC	32,013	$43K	0.0%	N/A	0.135%
8/13/2022	Renaissance Technologies LLC	169,400	$0.23M	0.0%	+748.8%	0.712%
8/2/2022	Thompson Davis & CO. Inc.	21,000	$28K	0.0%	N/A	0.088%
7/22/2022	Truist Financial Corp	33,862	$45K	0.0%	N/A	0.142%
7/13/2022	Private Advisor Group LLC	21,400	$29K	0.0%	-37.3%	0.090%
5/13/2022	Renaissance Technologies LLC	19,958	$40K	0.0%	N/A	0.084%
5/13/2022	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	35,000	$70K	0.0%	N/A	0.148%
11/12/2021	Oppenheimer & Co. Inc.	38,500	$0.17M	0.0%	+37.5%	0.190%
11/12/2021	NorthRock Partners LLC	10,000	$43K	0.0%	N/A	0.049%
10/29/2021	Commonwealth Equity Services LLC	36,461	$0.16M	0.0%	+25.5%	0.180%
9/17/2021	Virtu Financial LLC	31,038	$79K	0.0%	N/A	0.153%
8/16/2021	State Street Corp	48,954	$0.13M	0.0%	N/A	0.260%
8/13/2021	Northern Trust Corp	21,873	$56K	0.0%	N/A	0.116%
8/13/2021	Geode Capital Management LLC	88,246	$0.23M	0.0%	+13.2%	0.469%
8/13/2021	Vanguard Group Inc.	585,035	$1.49M	0.0%	+172.4%	3.112%
8/11/2021	Commonwealth Equity Services LLC	29,050	$74K	0.0%	+31.7%	0.155%
8/3/2021	Oppenheimer & Co. Inc.	28,000	$71K	0.0%	+93.1%	0.152%
7/17/2021	Golden Green Inc.	24,700	$63K	0.0%	N/A	0.134%
5/14/2021	Dimensional Fund Advisors LP	31,410	$76K	0.0%	+68.8%	0.179%
5/13/2021	Barclays PLC	15,850	$38K	0.0%	N/A	0.091%
5/12/2021	Rede Wealth LLC	15,000	$36K	0.0%	N/A	0.086%
5/10/2021	Oppenheimer & Co. Inc.	14,500	$35K	0.0%	N/A	0.083%
5/4/2021	Commonwealth Equity Services LLC	22,050	$53K	0.0%	+107.3%	0.126%
4/22/2021	Private Advisor Group LLC	36,650	$89K	0.0%	N/A	0.212%
3/8/2021	Dimensional Fund Advisors LP	18,612	$32K	0.0%	N/A	0.129%
2/25/2021	Dimensional Fund Advisors LP	18,612	$32K	0.0%	N/A	0.129%
2/10/2021	Renaissance Technologies LLC	98,900	$0.17M	0.0%	+6.5%	0.687%
12/11/2020	Virtu Financial LLC	18,902	$42K	0.0%	N/A	0.131%
8/14/2020	Bank of America Corp DE	150,000	$0.21M	0.0%	N/A	1.115%
8/14/2019	Vanguard Group Inc.	293,908	$0.49M	0.0%	-3.2%	2.875%
2/14/2019	Two Sigma Investments LP	11,775	$60K	0.0%	N/A	0.180%
2/13/2019	Geode Capital Management LLC	13,581	$69K	0.0%	N/A	0.207%
2/8/2019	BlackRock Inc.	205,684	$1.05M	0.0%	N/A	3.137%

Data available starting January 2016

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Today's Range

Now: $2.03

$1.85

$2.22

50 Day Range

MA: $2.30

$1.91

$3.00

52 Week Range

Now: $2.03

$1.77

$15.00

Volume

236,218 shs

Average Volume

95,907 shs

Market Capitalization

$2.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Who are the company insiders with the largest holdings of Adial Pharmaceuticals?: Adial Pharmaceuticals' top insider shareholders include:
Kevin Schuyler (Director)
Learn More about top insider investors at Adial Pharmaceuticals.
Who are the major institutional investors of Adial Pharmaceuticals?: Adial Pharmaceuticals' top institutional investors include:
Manchester Capital Management LLC — 3.94%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Adial Pharmaceuticals stock.
Which institutional investors are selling Adial Pharmaceuticals stock?: In the previous quarter, ADIL stock was sold by these institutional investors:
Manchester Capital Management LLC